Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study ; volume:21 ; number:1 ; day:31 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
BMC medicine ; 21, Heft 1 (31.10.2023), 1-11, 12.2023
- Urheber
-
Luo, Shan
Lam, Hugh Simon
Chan, Yap Hang
Tang, Clara Sze Man
He, Baoting
Kwok, Man Ki
Leung, Gabriel M.
Schooling, C Mary
Au Yeung, Shiu Lun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-023-03115-y
- URN
-
urn:nbn:de:101:1-2024011720595082786986
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Luo, Shan
- Lam, Hugh Simon
- Chan, Yap Hang
- Tang, Clara Sze Man
- He, Baoting
- Kwok, Man Ki
- Leung, Gabriel M.
- Schooling, C Mary
- Au Yeung, Shiu Lun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Common Methods for Performing Mendelian Randomization
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Common Methods for Performing Mendelian Randomization
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study